34007205|t|Serum 3-Hydroxybutyrate in Patients with Psychogenic Somatoform Symptoms May Be a Predictor of the Effectiveness of Sertraline and Venlafaxine.
34007205|a|BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) and serotonin-noradrenaline reuptake inhibitors (SNRIs) are often used to treat outpatients with psychogenic somatoform symptoms but prove ineffective in some cases. The metabolite 3-hydroxybutyrate (3HB) is currently attracting attention as a marker of the severity of depression. We investigated whether serum 3HB levels in patients with psychogenic somatoform symptoms can predict the effectiveness of sertraline and venlafaxine. PATIENTS AND METHODS: Physical and psychiatric problems were assessed in 132 outpatients, and symptomatic response and serum 3HB concentrations were examined before and after treatment with sertraline (50 mg/day) or venlafaxine (75 mg/day). RESULTS: In 30.3% of patients with psychogenic symptoms, serum 3HB was above the upper limit of normal (<80 mumol/L). According to multiple logistic regression analysis, only episodes of suicidal ideation showed a significant positive association with elevated 3HB (odds ratio 10.2; 95% confidence interval (CI) 2.46-42.2). The sensitivity of 3HB for the effectiveness of sertraline or venlafaxine for psychosomatic symptoms was 44.6%, but specificity was 93.9%. Hierarchical multiple logistic regression analysis identified 3HB as a better predictor of the effectiveness of medication (odds ratio 10.0; 95% CI, 2.49-40.3) than episodes of suicidal ideation. CONCLUSION: The present findings suggest that high serum 3HB levels in patients with psychogenic somatoform symptoms may be associated with suicidal ideation and the effectiveness of sertraline and venlafaxine at low to intermediate doses. The 3HB level may be a good predictor of the effectiveness of medication. Examination of serum 3HB levels may lead to earlier and more appropriate administration of sertraline and venlafaxine.
34007205	6	23	3-Hydroxybutyrate	Chemical	MESH:D020155
34007205	27	35	Patients	Species	9606
34007205	41	72	Psychogenic Somatoform Symptoms	Disease	MESH:D013001
34007205	116	126	Sertraline	Chemical	MESH:D020280
34007205	131	142	Venlafaxine	Chemical	MESH:D000069470
34007205	208	251	serotonin-noradrenaline reuptake inhibitors	Chemical	-
34007205	253	258	SNRIs	Chemical	-
34007205	301	332	psychogenic somatoform symptoms	Disease	MESH:D013001
34007205	385	402	3-hydroxybutyrate	Chemical	MESH:D020155
34007205	404	407	3HB	Chemical	MESH:D020155
34007205	474	484	depression	Disease	MESH:D003866
34007205	516	519	3HB	Chemical	MESH:D020155
34007205	530	538	patients	Species	9606
34007205	544	575	psychogenic somatoform symptoms	Disease	MESH:D013001
34007205	609	619	sertraline	Chemical	MESH:D020280
34007205	624	635	venlafaxine	Chemical	MESH:D000069470
34007205	637	645	PATIENTS	Species	9606
34007205	672	683	psychiatric	Disease	MESH:D001523
34007205	762	765	3HB	Chemical	MESH:D020155
34007205	827	837	sertraline	Chemical	MESH:D020280
34007205	853	864	venlafaxine	Chemical	MESH:D000069470
34007205	899	907	patients	Species	9606
34007205	913	933	psychogenic symptoms	Disease	MESH:D020821
34007205	941	944	3HB	Chemical	MESH:D020155
34007205	1065	1082	suicidal ideation	Disease	MESH:D001072
34007205	1139	1142	3HB	Chemical	MESH:D020155
34007205	1221	1224	3HB	Chemical	MESH:D020155
34007205	1250	1260	sertraline	Chemical	MESH:D020280
34007205	1264	1275	venlafaxine	Chemical	MESH:D000069470
34007205	1280	1302	psychosomatic symptoms	Disease	MESH:D011602
34007205	1403	1406	3HB	Chemical	MESH:D020155
34007205	1518	1535	suicidal ideation	Disease	MESH:D001072
34007205	1594	1597	3HB	Chemical	MESH:D020155
34007205	1608	1616	patients	Species	9606
34007205	1622	1653	psychogenic somatoform symptoms	Disease	MESH:D013001
34007205	1677	1694	suicidal ideation	Disease	MESH:D001072
34007205	1720	1730	sertraline	Chemical	MESH:D020280
34007205	1735	1746	venlafaxine	Chemical	MESH:D000069470
34007205	1781	1784	3HB	Chemical	MESH:D020155
34007205	1872	1875	3HB	Chemical	MESH:D020155
34007205	1942	1952	sertraline	Chemical	MESH:D020280
34007205	1957	1968	venlafaxine	Chemical	MESH:D000069470
34007205	Association	MESH:D000069470	MESH:D020155
34007205	Negative_Correlation	MESH:D020280	MESH:D011602
34007205	Association	MESH:D020155	MESH:D020280
34007205	Negative_Correlation	MESH:D020280	MESH:D013001
34007205	Comparison	MESH:D000069470	MESH:D020280
34007205	Association	MESH:D020155	MESH:D020821
34007205	Association	MESH:D020155	MESH:D011602
34007205	Negative_Correlation	MESH:D000069470	MESH:D011602
34007205	Positive_Correlation	MESH:D020155	MESH:D001072
34007205	Association	MESH:D020155	MESH:D003866
34007205	Association	MESH:D020155	MESH:D013001
34007205	Negative_Correlation	MESH:D000069470	MESH:D013001

